Next Article in Journal
Investigating the Effect of School Bus Stopping Process on Driver Behavior of Surrounding Vehicles Based on a Driving Simulator Experiment
Next Article in Special Issue
Trans*Forming Access and Care in Rural Areas: A Community-Engaged Approach
Previous Article in Journal
Go Green and Recycle: Analyzing the Usage of Plastic Bags for Shopping in China
Previous Article in Special Issue
“I Have Nowhere to Go”: A Multiple-Case Study of Transgender and Gender Diverse Youth, Their Families, and Healthcare Experiences
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Trans Adults Amidst the COVID-19 Pandemic: Quality of Life, Pandemic Impact, and Vaccine Preferences

1
School of Social Work, University of Washington, Seattle, WA 98105, USA
2
Department of Psychology, East Carolina University, Greenville, NC 27858, USA
3
Silberman School of Social Work, City University of New York, New York, NY 10065, USA
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(23), 12536; https://doi.org/10.3390/ijerph182312536
Submission received: 13 October 2021 / Revised: 21 November 2021 / Accepted: 23 November 2021 / Published: 28 November 2021
(This article belongs to the Special Issue Health and Healthcare for Transgender and Gender Diverse Communities)

Abstract

:
The ongoing COVID-19 pandemic is disproportionately impacting marginalized communities, such as Black, Indigenous, and people of color (BIPOC), disabled individuals, and transgender/nonbinary (i.e., trans) individuals. As trans individuals may be multiply marginalized, it is necessary to examine within group differences among trans individuals of different genders, races, socioeconomic statuses, and abilities. This study examines the following research questions: (1) What is the quality of life of trans adults during the COVID-19 pandemic? (2) How does the self-reported impact of the pandemic vary across groups within the trans community? (3) What preferences do trans adults have regarding receiving a COVID-19 vaccine? Survey data were collected in August/September of 2020. Among a sample of 449 trans adults, findings suggest that the profound impact of the pandemic was not consistent across all community members. Being a woman predicted a higher self-reported impact of the pandemic while being a masc(uline) white respondent tended to predict a lower impact of the pandemic. Higher income was associated with a higher quality of life and being a disabled white respondent predicted a lower quality of life. The majority (99%) of the sample reported wanting to receive a COVID-19 vaccine should one become available. Implications for practice include the importance of considering the holistic experiences of clients and community members, as opposed to having homogenized perspectives of even subsets of the trans community. Future research related to barriers faced when attempting to access a vaccine is needed to inform future public health responses to epidemics/pandemics impacting this community.

1. Introduction

The ongoing COVID-19 pandemic is disproportionately impacting marginalized communities, such as Black, Indigenous, and people of color (BIPOC), disabled individuals, and transgender/nonbinary (i.e., trans) individuals [1,2,3]. Within the trans community, individuals may be multiply marginalized—that is, facing systemic oppression from more than one axis at once. For this reason, it is necessary to examine within group differences among trans individuals of different genders, races, socioeconomic statuses, and abilities. With this in mind, exploring differences within the trans community in regard to quality of life is a useful lens, especially during stressful societal events with differential impacts, such as the pandemic. The World Health Organization (WHO) defines quality of life as an “individuals’ perceptions of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns”, which includes the domains of physical health, psychological, social relationships, and the environment [4]. Studies of specific marginalized populations (e.g., people of color, older adults, disabled) have shown the connection between these domains, illustrating community-specific impacts between social relationships and health (e.g., lower mortality and higher self-reported health among older adults and African Americans) [5,6].
Disparate outcomes in transgender physical and mental health are increasingly well documented by researchers. Trans populations have been shown to have multiple increased risk factors (i.e., lack of acceptance, mental illness), a lack of protective factors (i.e., accepting families, a sense of community), and unmet needs (i.e., culturally competent medical and social service provision) [7,8,9,10,11,12,13]. Notably, the 2015 U.S. Trans Study (n = 27,715) found that 40% of transgender adults reported having attempted suicide at least once [11].
Despite documented increased risk factors, including heightened risk for HIV, HPV, and other conditions [14,15,16], trans individuals may avoid seeking medical attention. Nearly a quarter of respondents in the U.S. Trans Survey reported not seeing a doctor when they needed to for fear of being mistreated [11]. While a growing body of literature examines the experiences of trans individuals and healthcare providers, relatively little is known regarding attitudes towards or access to vaccines in trans communities. Multiple studies have found trans individuals partake in vaccine research to do their part to protect their community [14,15]. Andrasik and colleagues [14] found that trans individuals (n = 13) were more likely to maintain low HIV risk profiles and follow trial procedures than their cisgender (cis) counterparts (n = 681). In one study (n = 3529), Rutherford and colleagues [16] found that, while more likely to report being vaccinated for HPV than their cis counterparts, trans respondents were also more likely to report being denied the HPV vaccination than sexual minority cis men in the sample (4.1% vs. 1.6%). In their qualitative examination assessing knowledge of HIV vaccines among trans women, Taylor et al. [15] also identified barriers to HIV vaccine access, including fear of side effects or feeling excluded from biomedical research.
Trans individuals may also have lower access to or lack of trust in social services and healthcare due to lack of health insurance, poverty, a history of negative experiences, and/or lack of competent providers [17,18,19]. This lack of access is compounded during the COVID-19 crisis, as gender-affirming medical treatments were often postponed due to healthcare systems having to limit capacity [20]. As receiving necessary gender-affirming surgeries has been shown to be associated with redacted mental health problems, this is a dual crisis pertaining to both the physical and mental wellbeing of trans individuals [21]. Continued hormone replacement therapy is also a concern during the pandemic, as medical support and hormone access may wane [22]. Despite difficulties in accessing healthcare during the pandemic, there is some evidence that, through the availability of telehealth appointments, some trans individuals were able to initiate or continue their gender-affirming care in 2020 [23].
The COVID-19 pandemic provides a unique environment with unknown consequences for our mental and physical wellbeing. Social relationships (which may be impacted by social distancing) have been shown to have a causal association with positive health outcomes [24,25,26]. This research has shown the impact of social networks and support on both physical and mental health. High levels of social capital, that trans individuals might lack, have been linked to lower mortality rates and positive perceptions of health [27,28]. During a crisis like COVID-19, social support, coping, and resilience play an integral role in buffering the extreme levels of stress and anxiety faced by both the general population and marginalized communities such as trans, BIPOC, and/or disabled [29,30]. Umucu and Lee [31] found that, in a sample of individuals with disabilities and/or chronic conditions (n = 269), perceived stress related to COVID-19 was positively associated with both adaptive and maladaptive coping strategies such as self-distraction, denial, substance use, behavioral disengagement, venting, planning, religion, and self-blame.
Additionally, multiple studies have identified the predictive nature of self-perceived general health of chronic disease, use of medical services, disability, and mortality [5,6,32,33]. In a sample of 477 LGBTQ college students aged 19–25, Gonzales et al. [34] found that 79.1% of trans respondents reported experiencing frequent mental distress during April–June 2020. Comparatively, 36.5% of cisgender LGB men and 58.4% of cisgender LGB women reported experiencing frequent mental distress in the same time period. This study also found that nearly half (45.7%) of the sample reporting their immediate families—who they may or may not be quarantining with, did either not support or know about their LGBTQ identity. Studies of specific vulnerable populations (e.g., people of color, older adults, disabled) have shown community-specific impacts of the connection between social relationships and health [5,6]. The lack of social connection due to quarantining or isolating during the COVID-19 pandemic has a unique impact on trans and queer populations, including youth, who may lose a sense of a queer/trans community as a result [35]. This impact may be even more exacerbated on immigrant, Latine, and broader BIPOC communities within the trans community who are especially targeted by anti-trans violence [36]. Although there are similarities between the ways cisgender sexual minorities (i.e., LGB) navigate mental/physical health, trans communities have experiences unique to them and, therefore, it is important for researchers to examine these issues through a trans-specific lens with a focus on within group differences [22,37].
This is the first pandemic of this magnitude faced by the trans community since the 1980s, which was prior to the social sciences recognizing and studying the trans community separately from the broader LGBTQ community. To that end, it is necessary for social science scholars to consider the experiences of trans individuals in the face of a global health crisis. The current study contributes to the sparse existing knowledge of the wellbeing of trans individuals during the COVID-19 pandemic by addressing the following research questions: (1) What is the quality of life of trans adults during the COVID-19 pandemic? (2) How does the self-reported impact of the pandemic vary across groups (e.g., race, gender, class, ability) within the trans community? (3) What preferences do trans adults have regarding receiving a COVID-19 vaccine?

2. Methods

This cross-sectional survey was collected in August and September of 2020. Study data were collected and managed using REDCap electronic data capture tools hosted at the University of Washington [38,39]. This study (STUDY00010863) was approved by the University of Washington Institutional Review Board on 4 August 2020 and respondents completed an informed consent.

2.1. Sample and Recruitment

Participant include adults (18+) who are transgender, nonbinary, and/or some other gender minority or who have a history of transitioning their gender. Respondents were also required to read/write in English and access the survey online. Using g* power, with alpha set at 0.05, power (1-beta) set at 0.80, and assuming a small effect size (f^2 = 0.1), a sample size of 81 determined to be necessary to detect significance on the least-powered parameter in the intended analyses (betas in the multiple regression). Recruitment was conducted via social media (i.e., Facebook groups, ads on Instagram/Facebook) and professional/community networks (i.e., LGBTQ Caucus of Faculty & Students in Social Work listserv). Respondents were able to enter a raffle for a chance of one of five $25 gift cards.

2.2. Measures

To address the research questions related to COVID-19, 55 variables of the larger dataset of 256 variables are included. Additional QOL, community belonging, and social support data not related to COVID-19 and constituting the additional 200 variables—collected to assess other hypotheses—are not examined in these analyses. The current study includes 26 demographic variables such as age, gender, race, relationship status, political identity, gender expression, and disability status. Demographic variables were informed by the Behavioral Risk Factor Surveillance System (BRFSS) [40] and the U.S. Trans Survey [11]. Additionally, items related directly to the COVID-19 pandemic and respondent QOL were included and are detailed below.

2.2.1. BRFSS

Utilizing 13 items from the BRFSS [40], respondents were asked about their health and wellbeing, access to services, and social determinants of health. This included disability status, access to health insurance, and satisfaction with the healthcare they have received in the past year.

2.2.2. WHOQOL

Utilizing a selection of Likert scale items from the WHOQOL-BREF [4] respondents were asked questions pertaining to the four domains of QOL, as defined by the WHO (i.e., physical health, psychological, social relationships, and environment). For example, respondents were asked how safe they feel in their daily life, how often they had negative feelings in the past two weeks, and how satisfied they were with the quality of their sleep and sex life in the past two weeks.

2.2.3. COVID-19

Respondents were asked about the impact of COVID-19 on their lives and their preferences around a vaccine (i.e., if/when/how they would want to receive it). This also included items asking how many days they had cared for someone or worked outside their home in the past month.

2.3. Analysis

Proportions of missing data ranged from 2.67% (n = 12) (sexual orientation) to 22.27% (n = 100) (number of times visited a health professional in past year). Missing data was handled via generation of 50 imputation files using the mice package’s predictive mean matching in R [41,42]. Descriptive statistics, visual inspection of the data, and iteration histories were examined to ensure convergence. Relative efficiency was above 0.95 for all analyses indicating effective imputation. All analyses excluding descriptive statistics were performed on the imputed sample using SPSS 28 [43].

3. Results

3.1. Describing the Sample

Respondents include 449 individuals from 38 states (plus Washington D.C.), (n = 371) and 12 countries (including the United States). While 45 respondents indicated they lived in a country other than the United States, 27 of these were from Canada. Other countries included in the study (i.e., England, Norway, Korea, Argentina, Australia, Germany, Ireland, Scotland, Spain) were only represented by 1 to 7 respondents each. While all respondents were trans (including binary, nonbinary, and culturally specific identities), when asked to indicate which simplified gender category they most identified with, 279 (62.14%) respondents indicated they most identified as nonbinary, 114 (25.39%) as men, 51 (11.36%) as women, and 5 (1.11%) as a culturally specific gender. The sample was majority white (n = 335, 74.61%) or bi/multiracial (n = 64, 14.25%) (Table 1).
The mean age was 31.69 years and 65.92% (n = 296) were disabled and/or chronically ill. While 77.28% (n = 347) had completed an associates, bachelors, masters, or doctorate degree, 37.19% (n = 167) earned less than $20,000/year and 65.70% (n = 295) earned less than $40,000/year in 2019. Age was moderately correlated to income (r(447) = 0.29, p < 0.001), with the average age of those earning $75,000/year or more was 37.65 years, while the average age of those earning under $25,000/year was 29.51 years. When asked about their activity over the last month, 7% reported caring for someone else and 23% reported having worked outside their home for 14 or more days. Nine percent (n = 42) reported being unemployed due to the pandemic and 10% (n = 47) reported being unemployed due to other reasons. While the majority of the sample (n = 371, 82.63%) had begun transitioning (i.e., socially, legally, and/or medically aligning their gender) or had reached all of their transition goals, about two thirds of the sample (n = 296, 65.92%) were out to most people, almost everyone, or everyone in their lives. Additional demographic information of the sample is presented in Table A1 in Appendix A.
A quality of life score was computed using eight items from the WHOQOL-BREF measure, with a maximum score of 37 possible. Respondent’s QOL scores ranged from 15–31 (sd = 2.944, with a mean of 23.21 (Table 2)).

3.2. Predicting COVID-19 Impact & Quality of Life

Quality of life and self-reported impact of COVID-19 were found to be negatively correlated (r(447) = −0.111, p = 0.046), indicating an association between higher quality of life and lower impact of the pandemic. Quality of life was also positively correlated with annual individual income (r(447) = 0.123, p = 0.018). Additionally, being disabled and/or chronically ill was negatively correlated with quality of life (r(447) = −0.248, p < 0.001) and positively correlated with self-reported impact of the pandemic (r(447) = 0.116, p = 0.044).
Multiple linear regression models predicting the self-reported impact of COVID-19 were created. All efficiencies were reported at 0.95 or above. First, the variables of age, individual income (in U.S. dollars), gender, and race (0 = white, 1 = BIPOC) were tested as predictors. In the model predicting COVID-19 impact (R2 = 0.024, F(1449) = 0.272, p = 0.047), only being a woman significantly predicted a higher self-reported impact of the pandemic (Table 3).
To compare predictors of QOL and the impact of the pandemic, the variables of age, individual income (in U.S, dollars), gender, and race were tested as predictors of QOL. In the model predicting QOL (R2 = 0.033, F(1449) = 0.085, p = 0.006), only income significantly predicted higher QOL (Table 4).
Next, the variables of QOL, being disabled/chronically ill, fem(me), and the degree to which the respondent was out as trans to others were tested as predictors of the self-reported impact of the pandemic. In the model predicting COVID-19 impact (R2 = 0.024, F(1449) = 2.736, p = 0.081), no predictors reached statistical significance (Table 5).

3.3. Results by Race, Ability, and Gender

Gender identities (i.e., man, woman, nonbinary) and gender expressions (i.e., whether someone was masc(uline), fem(me), or androgynous) were found to be correlated with one another (Table 6). Gender expression categories were not mutually exclusive, as respondents may have fluid or multi-faceted ways of presenting themselves. Both odds ratios using a logistic regression and linear regression were used to examine intersectional experiences based on race, ability, and gender expression. While highly correlated, we utilized gender expression in subsequent analyses, since it is likely more consistent with social perceptions of individuals’ genders and may, therefore, have larger influence on how individuals are treated by others (as compared to internal gender identity).
Dummy variables for fem(me) BIPOC (n = 29, 6.4%), masc(uline) white (n = 172, 38.3%), masc(uline) BIPOC (n = 53, 11.8%), fem(me) white (n = 97, 21.6%), white and disabled (n = 216, 48.0%), BIPOC and disabled (n = 76, 17%), BIPOC, nondisabled white (n = 118, 26.28%), and nondisabled BIPOC (n = 34, 7.57%) respondents in the sample were created so that the relationship between these groups and independent variables of interest could be examined (Table 7). Though some groups had slightly higher or lower odds of being low income, they failed to reach significance. While masc(uline) BIPOC respondents had 56% higher odds (p = 0.043), disabled white and disabled BIPOC respondents had lower odds (45% (p < 0.001) and 27% (p = 0.009), respectively) of reporting feeling “very much” or “extremely safe” in their daily life during the past two weeks.
Next, QOL and COVID-19 impact were predicted using linear regression based on the above intersecting identity groups. In this model (R2 = 0.074, F(1449) = 5.893, p < 0.001), disabled white respondents reported lower qualities of life (p < 0.001) than other groups (Table 8). In the model predicting COVID-19 impact (R2 = 0.043, F(1449) = 3.315, p = 0.014), being a masculine white respondent predicted reporting a lower impact of the pandemic (p = 0.025) (Table 9).

3.4. Vaccine Preferences

Utilizing non-mutually exclusive items, respondents were asked about their preferences regarding receiving a COVID-19 vaccine (Table 10). Overall, 98.9% (n = 444) of the sample (99.6% of white respondents and 96.7% of BIPOC respondents) reported they would want to receive a vaccine should it become available. While just over a third of respondents (36.5%, n = 164) indicated they would want to receive a COVID-19 vaccine as soon as possible (37.9% of white respondents and 32.4% of BIPOC respondents), a third of respondents (n = 150, 33.4%) reported they would only want to receive it after side effects had been shown to be minimal or manageable. Additionally, a third of respondents (33.0%, n = 148) reported they would only want to receive the vaccine after other, more vulnerable groups (such as chronically ill individuals or older adults) had been able to receive it. While 12.7% of respondents (n = 57) would prefer to wait until it had been used by others for at least one month, 9.1% (n = 41) and 2.2% (n = 10) of the sample would prefer to wait 6 months or a year, respectively. Only 0.4% of the sample (n = 2) would only want to receive it if available via nasal spray instead of a shot.
Almost half (45.99%, n = 63) of individuals with both mental and physical health conditions would prefer to receive the vaccine as soon as possible, while only 12.3% (n = 14) of individuals with neither physical nor mental health conditions would opt to do so. Additionally, individuals with both physical and mental health conditions (n = 56, 40.9%) reported preferring to wait until the vaccine had been shown to have minimal side effects (as compared to 7.9%, n = 9 of those without health conditions).
While almost half (n = 23, 45.1%) of respondents who earned $75,000/year would prefer to receive a vaccine as soon as possible, only 25.5% (n = 13) would wait until other, more vulnerable groups had received it. Almost half (n = 85, 45.5%) of individuals with only mental health conditions (with no physical health conditions) reported preferring to wait until other, more vulnerable groups had received a vaccine, though a similar number of these individuals reported wanting to receive the vaccine ASAP (n = 84, 44.9%) or after minimal side effects had been shown (n = 78, 41.7%). Roughly a third of the BIPOC in the sample (n = 84, 44.9%) reported wanting to be vaccinated as soon as possible (n = 36, 32.4%), while 30.6% (n = 34) would want to wait until minimal side effects had been shown.

4. Discussion

This study sought to examine the quality of life and vaccine preferences of trans adults during a snapshot of a global pandemic. Given the dearth of literature on vaccine preferences among trans individuals, this study makes an important contribution to the existing literature. Collected during August and September of 2020, these findings suggest that, while the COVID-19 pandemic profoundly impacted the trans community, this impact was not consistent across all community members. As reflected in many other studies, trans individuals of different identities do not move through the world as one identity at a time [9,11,22,34,37]. For this reason, analytic methods to consider multiple axes of identity/experience at once were used. In addition to informing provider-client interactions, findings from this study can be used to inform vaccine booster roll-out, programs in response to the COVID-19 pandemic or other crises, and health-related policy.
After COVID cases reached a second peak in the U.S. in mid-July, they slowly decreased from July to mid-September (when they began increasing once more) [44]. On 31 August 2020, the 7-day average number of new cases in the U.S. was 41,6000. However, the geographic region where respondents were residing at the time of data collection had a variety of policies and practices in place in response to the pandemic. The states with the most respondents included: Washington (n = 122), Illinois (n = 35), and California (n = 22). In California, COVID-19 positivity rates were hitting a record low in September, following outbreaks in state prisons and implementing the “Blueprint for a Safer Economy framework” the month before [45,46]. Using the Blueprint framework, each county in California was assigned a risk-level tier based on positivity rate, adjusted case rate, and/or health equity metric [46,47]. Though rates were lower than in July and August of 2020, as of 31 September 2020, 38 of the 58 counties were in Tier 1 [46,47]. This tier indicated the virus was widespread and meant most schools were closed to in-person instruction, there were more than 10 daily new cases per 100,000 residents, and indoor business operations were suspended or severely limited [46]. Meanwhile in Canada, cases very slightly peaked in July 2020 (after easing some restriction to in-person activities early in July) and then increased steadily from early August 2020 through January 2021 [48,49]. In August and September, education and other in-person activities mostly took place with mask-wearing and social distancing [49]. As of 1 August 2020, there were 337 new COVID cases, compared to 2168 new cases on 1 October 2020 [48,49]. Thus, Canadian and international respondents, while still experiencing disruptions to daily life, had lower COVID exposure risk, yet were experiencing higher restrictions than US respondents.
While some research regarding the COVID-19 pandemic and quality of life is starting to be published, results regarding the specific impact on trans communities are still rare. One study regarding the impact of the first three months of the COVID-19 pandemic on trans Australians (N = 1019) [3] found that 49% of respondents reported thoughts of self-harm or suicide and 61.5% experienced clinically significant symptoms of depression. Further, half their sample reported experiencing financial strain and almost a quarter (22.4%) were unemployed [3]. More research is needed to better understand, and thus better serve, trans individuals during the current and future health crises.
COVID-19′s impact on cisgender community members is better understood. Mendes and Pereira [50] for example, found that LGB individuals (especially bisexuals) suffered more severe impacts of COVID-19 and had lower work-related QOL than heterosexual respondents, but did not examine the difference between respondents of different genders and did not ask respondents if they were transgender. In the current study, respondents were asked what the impact of COVID-19 had been on their lives overall (ranging from insignificant to catastrophic). Women overall in the sample reported a greater impact of the pandemic, though being masc(uline) and white or a nondisabled BIPOC respondent predicted reporting a lower impact of the pandemic. On average, disabled white respondents reported a lower QOL. Those with higher incomes reported a higher QOL, compared to those with lower incomes in the sample. Having a higher quality of life or being a masc(uline) white respondent was associated with reporting a lower impact of the pandemic. These findings align with other studies [51,52,53,54] that illustrate how varied experiences can be, even within subgroups (e.g., BIPOC, lower income, disabled) of larger communities.
Results from this study illustrate the profound differences of experiences within the trans community, especially in regard to disability. While between 15–25% of adults in the United States is disabled [55,56] about two thirds of the current sample reported being disabled and/or chronically ill. This is higher than the 39% of respondents in the U.S. Trans Survey who reported having a disability [11] or the 55% of the respondents in the Trans PULSE Canada study who reported being disabled or chronically ill [57]. In the current study, being disabled and/or chronically ill was associated with lower quality of life and higher self-reported impact of the pandemic. Though being disabled/chronically ill alone did not predict pandemic impact, being a white disabled and/or chronically ill respondent predicted reporting lower QOLs than other respondents, which aligns with prior research regarding disability and QOL [52,54]. Future analysis of the current study will more deeply examine the quality of life of disabled trans adults during the pandemic.
At the time of the data collection, no COVID-19 vaccine was publicly available yet. Distrust of the medical community, including vaccine provision, exists in multiple marginalized communities, including the trans community, due to historical and current mistreatment [18,58,59]. However, Matijczak and colleagues [60] found that gender and sexual minority (GSM) respondents were not more likely to delay or avoid testing/treatment for COVID-19, as compared to their non-GSM counterparts. Rutherford and colleagues [16] found that trans participants (n = 446) were more likely to report both being vaccinated for HPV and being denied the HPV vaccination than the sexual minority cis men (n = 3083) in the sample. Future research should examine whether trans individuals experienced barriers to receiving COVID-19 vaccinations and policy/practice shifts ensuring these barriers are not reproduced in the future must be made.
Findings from this study add to the burgeoning body of knowledge regarding differential experiences of trans individuals across multiple axes of identity and experience. The need to underscore the importance of emphasizing and honoring differences within communities remains. The variation in how the COVID-19 pandemic impacted different subgroups within the trans community, as well as the differences reported in quality of life, is no accident. Systems of oppression (including white supremacy, ableism, and misogyny) are utilized by individuals and institutions in power to heighten the impact of illness, poverty, and environmental issues on minoritized communities. When ensuring programs and practices are responsive to the needs of trans individuals, practitioners must not assume that an individual is either trans or BIPOC or disabled; rather, social service and healthcare provision should be shaped with the assumption that our clients hold multiple targeted identities. As these are systemic- and societal-level mechanisms, educators and practitioners must also include a focus on mezzo/macro interventions (e.g., policy, funding, culture shift).

Strengths and Limitations

This study has multiple strengths and limitations that should be considered when interpreting findings. While disabled and/or chronically ill members of the trans community are highly represented within the sample, there are small subgroups (i.e., Alaskan Native, Middle Eastern, Pacific Islander) within BIPOC respondents. Additionally, though there were many genders represented in the sample, only 11.3% (n = 50) of the respondents identified primarily as binary trans women. However, as the data were collected in August and September of 2020, they provide a valuable snapshot of the experiences of trans individuals during the COVID-19 pandemic. While the sample is not a representative random sample, the sample does reflect a variety of regions in the United States and includes a subsample of individuals from outside the U.S. context. With 449 respondents, the sample size did allow for multivariate analysis and considering the experiences of groups by multiple facets of their identity/experiences (e.g., masc(uline) BIPOC).

5. Conclusions

Limitations notwithstanding, this study provides much-needed data about trans adults during the COVID-19 pandemic. Healthcare providers, social workers, researchers, and those involved in writing policy need data examining the experiences and needs of the trans community through multiple layered lenses—not gender modality alone—in order to ensure we are truly responding to the community’s needs and experiences. Future research related to barriers faced when attempting to access a vaccine, the experiences of disabled trans adults, and to better understand the impact of health crises on trans communities is needed to inform future public health responses to epidemics/pandemics impacting this community.

Author Contributions

Conceptualization, V.H. and J.S.; methodology, V.H. and A.K.M.; software, V.H. and A.K.M.; validation, V.H. and A.K.M.; formal analysis, V.H.; investigation, V.H.; data curation, V.H.; writing—original draft preparation, V.H. and J.S.; writing—review and editing, V.H. and A.K.M.; supervision, V.H. and J.S.; project administration, V.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of the University of Washington (STUDY00010863, 4 August 2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical and privacy concerns.

Acknowledgments

The authors thank Kalei Kanuha and Clara Berridge for their expertise and assistance throughout the conceptualization of this study.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table A1. Demographics and descriptive information.
Table A1. Demographics and descriptive information.
COVID ImpactCOVID CareCOVID WorkLife SatisfactionHealth Self
Report
Safe WHOQOLNegative
Feelings
Social SupportTotal
Major or
Catastrophic
7+ Days Outside of Home in Last Month7+ Days Outside of Home in Last MonthSatisfied or Very SatisfiedGood to ExcellentVery Much or ExtremelyOften/Always Past 2 WeeksUsually/Always Receive
Needed Support
n%n%n%n%n%n%n%n%n%
Age
18–243842.70%66.74%3438.20%5966.29%5460.67%4651.69%4752.81%4247.19%8919.82%
25–3410947.39%3414.78%6729.13%16370.87%14964.78%11550.00%13458.26%14161.30%23051.22%
35–443943.82%55.62%3033.71%6573.03%6168.54%5056.18%6269.66%4853.93%8919.82%
45+1843.90%819.51%614.63%2560.98%2458.54%2356.10%2970.73%1741.46%419.13%
Gender
women2752.94%35.88%1835.29%3262.75%3262.75%2345.10%1631.37%2549.02%5111.36%
men4236.84%1614.04%3328.95%8372.81%8372.81%6960.53%3328.95%6153.51%11425.39%
nonbinary13547.54%3612.68%8630.28%19769.37%17360.92%14149.65%12845.07%16257.04%28463.25%
Race
white15445.97%3911.64%10029.85%23469.85%22165.97%17652.54%13239.40%18354.63%33574.61%
BIPOC4843.24%1513.51%3733.33%7668.47%6659.46%5650.45%4338.74%6457.66%11124.72%
Disabled and/or Chronically Ill
yes14649.32%4214.19%9130.74%19064.19%15753.04%13244.59%13344.93%15452.03%29665.92%
no5737.25%127.84%4630.07%12279.74%13185.62%10266.67%4428.76%9562.09%15334.08%
Income
none1545.45%412.12%412.12%2060.61%1545.45%1648.48%1545.45%1854.55%337.35%
<20 k6246.27%139.70%4231.34%7757.46%7757.46%6347.01%5843.28%6548.51%13429.84%
20–40 k6853.13%1511.72%4938.28%9372.66%7860.94%6147.66%5240.63%7155.47%12828.51%
40–75 k3937.86%1312.62%2827.18%8481.55%7976.70%6361.17%3836.89%6260.19%10322.94%
75 k+2039.22%917.65%1427.45%3874.51%3874.51%3058.82%1529.41%3364.71%5111.36%
Employed full time
yes7437.56%2512.69%7940.10%15779.70%14674.11%11357.36%7035.53%12462.94%19743.88%
no13051.59%2911.51%5823.02%15561.51%14256.35%12148.02%10742.46%12449.21%25256.12%
Live in the U.S.
yes18646.38%4811.97%12631.42%28470.82%25663.84%20651.37%16440.90%22455.86%40189.31%
no1837.50%612.50%1122.92%2858.33%3266.67%2858.33%1327.08%2450.00%4810.69%
Total20445.43%5412.03%13730.51%31269.49%28864.14%23452.12%17739.42%24855.23%449100%

References

  1. Cahill, S.R. Still in the Dark Regarding the Public Health Impact of COVID-19 on Sexual and Gender Minorities. Am. J. Public Health 2021, 111, e1–e4. [Google Scholar] [CrossRef]
  2. Ivers, L.C.; Walton, D.A. COVID-19: Global Health Equity in Pandemic Response. Am. J. Trop. Med. Hyg. 2020, 102, 1149–1150. [Google Scholar] [CrossRef] [Green Version]
  3. Zwickl, S.; Angus, L.; Qi, A.; Ginger, A.; Eshin, K.; Cook, T.; Leemaqz, S.Y.; Dowers, E.; Zajac, J.D.; Cheung, A. The impact of the first three months of the COVID-19 pandemic on the Australian trans community. Int. J. Transgender Health 2021, 1–11. [Google Scholar] [CrossRef]
  4. The WHOQOL Group. Development of the World Health Organization. WHOQOL-BREF quality of life assessment. Psychol. Med. 1998, 28, 551–558. [Google Scholar] [CrossRef] [Green Version]
  5. Ferraro, K.F.; Farmer, M.M.; Wybraniec, J.A. Health trajectories: Long-term dynamics among black and white adults. J. Health Soc. Behav. 1997, 38, 38–54. [Google Scholar] [CrossRef] [PubMed]
  6. Wilcox, V.L.; Kasl, S.V.; Idler, E.L. Self-rated health and physical disability in elderly survivors of a major medical event. J. Gerontol. Soc. Sci. 1996, 51, S96–S104. [Google Scholar] [CrossRef] [PubMed]
  7. Acevedo-Polakovich, I.; Bell, B.; Gamache, P.; Christian, A.S. Service accessibility for lesbian, gay, bisexual, transgender, and questioning youth. Youth Soc. 2013, 45, 75–97. [Google Scholar] [CrossRef]
  8. Budge, S.L.; Rossman, H.K.; Howard, K.A.S. Coping and psychological distress among genderqueer individuals: The moderating effect of social support. J. LGBT Issues Couns. 2014, 8, 95–117. [Google Scholar] [CrossRef]
  9. Durso, L.E.; Gates, G.J. Serving Our Youth: Findings from a National Survey of Service Providers Working with Lesbian, Gay, Bisexual, and Transgender Youth who are Homeless or At Risk of Becoming Homeless; The Williams Institute with True Colors Fund and The Palette Fund: Los Angeles, CA, USA, 2012. [Google Scholar]
  10. Forge, N. A Longitudinal Investigation of Risk and Resiliency among Homeless LGBT Youth Residing in a Transitional Living Shelter; ProQuest Dissertations Publishing: Ann Arbor, MI, USA, 2013. [Google Scholar]
  11. James, S.E.; Herman, J.L.; Rankin, S.; Keisling, M.; Mottet, L.; Anafi, M. The Report of the 2015 U.S. Transgender Survey; National Center for Transgender Equality: Washington, DC, USA, 2016. [Google Scholar]
  12. Scourfield, J.; Roen, K.; McDermott, L. Lesbian, gay, bisexual and transgender young people’s experiences of distress: Resilience, ambivalence and self-destructive behaviour. Health Soc. Care Community 2008, 16, 329–336. [Google Scholar] [CrossRef] [PubMed]
  13. Su, D.; Irwin, J.; Fisher, C.; Ramos, A.; Kelley, M.; Mendoza, D.; Coleman, J. Mental Health Disparities Within the LGBT Population: A Comparison Between Transgender and Nontransgender Individuals. Transgender Health 2016, 1, 12–20. [Google Scholar] [CrossRef] [Green Version]
  14. Andrasik, M.; Grove, D.; Broder, G.; Scott, H.; Allen, M.; Karuna, S. A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru. Vaccine 2019, 37, 3911–3917. [Google Scholar] [CrossRef]
  15. Taylor, N.; Young, M.; Williams, V.; Benitez, J.; Usher, D.; Hammer, S.; Tieu, H.-V.; Sobieszczyk, M. Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State Area. Transgender Health 2020, 5, 116–121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Rutherford, L.; Stark, A.; Ablona, A.; Klassen, B.J.; Higgins, R.; Jacobsen, H.; Draenos, C.J.; Card, K.G.; Lachowsky, N.J. Health and well-being of trans and non-binary participants in a community-based survey of gay, bisexual, and queer men, and non-binary and Two-Spirit people across Canada. PLoS ONE 2021, 16, e0246525. [Google Scholar] [CrossRef] [PubMed]
  17. Bauer, G.; Boyce, M.; Coleman, T.; Kaay, M.; Scanlon, K. Who are Trans People in Ontario? Trans PULSE e-Bulletin, Downloadable in English or French. 20 July 2010. Volume 1. Available online: https://www.transpulseproject.ca (accessed on 15 August 2021).
  18. Romanelli, M.; Hudson, K. Individual and Systemic Barriers to Health Care: Perspectives of Lesbian, Gay, Bisexual, and Transgender Adults. Am. J. Orthopsychiatry 2017, 87, 714–728. [Google Scholar] [CrossRef] [PubMed]
  19. Scheim, A.I.; Zong, X.; Giblon, R.; Bauer, G.R. Disparities in access to family physicians among transgender people in Ontario, Canada. Int. J. Transgenderism 2017, 18, 343–352. [Google Scholar] [CrossRef]
  20. Van der Miesen Anna, I.R.; Raaijmakers, D.; Van de Grift Tim, C. “You Have to Wait a Little Longer”: Transgender (Mental) Health at Risk as a Consequence of Deferring Gender-Affirming Treatments During COVID-19. Arch. Sex. Behav. 2020, 49, 1395–1399. [Google Scholar] [CrossRef]
  21. Bränström, R.; Pachankis, J.E. Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: A total population study. Am. J. Psychiatry 2020, 177, 727–734. [Google Scholar] [CrossRef]
  22. Wang, Y.; Pan, B.; Liu, Y.; Amanda, W.; Ou, J.; Chen, R. Health care and mental health challenges for transgender individuals during the COVID-19 pandemic. Lancet Diabetes Endocrinol. 2020, 8, 564–565. [Google Scholar] [CrossRef]
  23. Lock, L.; Anderson, B.; Hill, B.J. Transgender Care and the COVID-19 Pandemic: Exploring the Initiation and Continuation of Transgender Care In-Person and Through Telehealth. Transgender Health 2021. [Google Scholar] [CrossRef]
  24. Egan, M.; Tannahill, C.; Petticrew, M.; Thomas, S. Psychosocial risk factors in home and community settings and their associations with population health and health inequalities: A systematic meta-review. BMC Public Health 2008, 8, 239. [Google Scholar] [CrossRef] [Green Version]
  25. Holt-Lunstad, J.; Smith, T.B.; Layton, J.B. Social relationships and mortality risk: A meta-analytic review. PLoS Med. 2010, 7, e1000316. [Google Scholar] [CrossRef]
  26. Shields, M. Community belonging and self-perceived health. Health Rep. 2008, 19, 51–60. [Google Scholar]
  27. Kawachi, I.; Kennedy, B.P.; Glass, R. Social capital and self-rated health: A contextual analysis. Am. J. Public Health 1999, 89, 1187–1193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Kennedy, B.; Kawachi, I.; Prothrow-Stith, D.; Lochner, K.; Gupta, V. Social capital, income inequality, and firearm violent crime. Soc. Sci. Med. 1998, 47, 7–17. [Google Scholar] [CrossRef]
  29. Goldbach, C.; Knutson, D.; Milton, D.C. LGBTQ+ People and COVID-19: The Importance of Resilience During a Pandemic. Psychol. Sex. Orientat. Gend. Divers. 2020, 6, 123–132. [Google Scholar] [CrossRef]
  30. Szkody, E.; Stearns, M.; Stanhope, L.; McKinney, C. Stress-Buffering Role of Social Support during COVID-19. Fam. Process 2021, 60, 1002–1015. [Google Scholar] [CrossRef] [PubMed]
  31. Umucu, E.; Lee, B. Examining the impact of COVID-19 on stress and coping strategies in individuals with disabilities and chronic conditions. Rehabil. Psychol. 2020, 65, 193–198. [Google Scholar] [CrossRef]
  32. Idler, E.L.; Benyamini, Y. Self-rated health and mortality: A review of twenty-seven community studies. J. Health Soc. Behav. 1997, 38, 21–37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Kaplan, G.A.; Goldberg, D.E.; Everson, S.A.; Cohen, R.D.; Salonen, R.; Tuomilehto, J.; Salonen, J. Perceived health status and morbidity and mortality: Evidence from the Kuopio ischaemic heart disease risk factor study. Int. J. Epidemiol. 1996, 25, 259–265. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Gonzales, G.; Loret de Mola, E.; Gavulic, K.A.; McKay, T.; Purcell, C. Mental Health Needs Among Lesbian, Gay, Bisexual, and Transgender College Students During the COVID-19 Pandemic. J. Adolesc. Health 2020, 67, 645–648. [Google Scholar] [CrossRef] [PubMed]
  35. Paceley, M.S.; Okrey-Anderson, S.; Fish, J.N.; McInroy, L.; Lin, M. Beyond a shared experience: Queer and trans youth navigating COVID-19. Qual. Soc. Work 2021, 20, 97–104. [Google Scholar] [CrossRef] [PubMed]
  36. Valdes, L. In the Shadow of the Health-Care City: Historicizing Trans Latinx Immigrant Experiences during the Coronavirus Pandemic. US Lat. Lat. Oral Hist. J. 2021, 5, 32–65. [Google Scholar] [CrossRef]
  37. Gibb, J.K.; DuBois, L.Z.; Williams, S.; McKerracher, L.; Juster, R.P.; Fields, J. Sexual and gender minority health vulnerabilities during the COVID-19 health crisis. Am. J. Hum. Biol. 2020, 32, e23499. [Google Scholar] [CrossRef] [PubMed]
  38. Harris, P.A.; Taylor, R.; Minor, B.L.; Elliott, V.; Fernandez, M.; O’Neal, L.; McLeod, L.; GDelacqua, G.; Delacqua, F.; Kirby, J.; et al. REDCap Consortium, The REDCap consortium: Building an international community of software partners. J. Biomed. Inform. 2019. [Google Scholar] [CrossRef] [PubMed]
  39. Harris, P.A.; Taylor, R.; Thielke, R.; Payne, J.; Gonzalez, N.; Conde, J.G. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009, 42, 377–381. [Google Scholar] [CrossRef] [Green Version]
  40. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA, USA, 2020. [Google Scholar]
  41. Buuren, S.V.; Groothuis-Oudshoorn, K. Mice: Multivariate imputation by chained equations in R. J. Stat. Softw. 2011, 45, 1–67. [Google Scholar] [CrossRef] [Green Version]
  42. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2019. [Google Scholar]
  43. IBM Corp. In IBM SPSS Statistics for Windows, Version 28.0. Released 2021; IBM Corp: Armonk, NY, USA.
  44. Coronavirus in the U.S.: Latest Map and Case Count. The New York Times, 13 November 2021. Available online: https://www.nytimes.com/interactive/2021/us/covid-cases.html (accessed on 13 November 2021).
  45. Procter, R. Remember When? Timeline Marks Key Events in California’s Year-Long Pandemic Grind; CalMatters: Sacramento, CA, USA, 2021; Available online: https://calmatters.org/health/coronavirus/2021/03/timeline-california-pandemic-year-key-points/ (accessed on 13 November 2021).
  46. State of California. Current Safety Measures. Coronavirus COVID-19 Response. 4 November 2021. Available online: https://covid19.ca.gov/safely-reopening/ (accessed on 13 November 2021).
  47. California Department of Public Health. California Blueprint Data Archive. 15 June 2021. Available online: https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/CaliforniaBlueprintDataCharts.aspx (accessed on 13 November 2021).
  48. Public Health Agency of Canada. Covid-19 Daily Epidemiology Update. Canada.ca. 28 May 2021. Available online: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html (accessed on 13 November 2021).
  49. Covid-19: Recovery and Re-Opening Tracker. McCarthy Tétrault. 10 November 2021. Available online: https://www.mccarthy.ca/en/insights/articles/covid-19-recovery-and-re-opening-tracker (accessed on 13 November 2021).
  50. Mendes, C.; Pereira, H. Assessing the Impact of COVID-19 on Work-Related Quality of Life through the Lens of Sexual Orientation. Behav. Sci. 2021, 11, 58. [Google Scholar] [CrossRef]
  51. Brennan, D.; Spencer, A. Health-related quality of life and income-related social mobility in young adults. Health Qual. Life Outcomes 2014, 12, 52. [Google Scholar] [CrossRef] [Green Version]
  52. Ćwirlej-Sozańska, A.; Wiśniowska-Szurlej, A.; Wilmowska-Pietruszyńska, A.; Sozański, B. Factors associated with disability and quality of life among the oldest-old living in community in Poland—A cross-sectional study. Ann. Agric. Environ. Med. 2020, 27, 621–629. [Google Scholar] [CrossRef]
  53. Hughes, M.; Thomas, M. The Continuing Significance of Race Revisited: A Study of Race, Class, and Quality of Life in America, 1972 to 1996. Am. Sociol. Rev. 1998, 63, 785–795. [Google Scholar] [CrossRef]
  54. Mack, S.; Jacobi, F.; Beesdo-Baum, K.; Gerschler, A.; Strehle, J.; Höfler, M.; Busch, M.A.; Maske, U.; Hapke, U.; Gaebel, W.; et al. Functional disability and quality of life decrements in mental disorders: Results from the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Eur. Psychiatry 2015, 30, 793–800. [Google Scholar] [CrossRef]
  55. Okoro, C.A.; Hollis, N.D.; Cyrus, A.C.; Griffin-Blake, S. Prevalence of Disabilities and Health Care Access by Disability Status and Type Among Adults—United States. MMWR Morb. Mortal Wkly. Rep. 2016, 67, 882–887. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. U.S. Census Bureau. 2015 American Survey 1-Year Estimates: Disability Characteristics. 2015. Available online: http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_15_1YR_S1810&prodType=table (accessed on 15 August 2021).
  57. Pyne, J.; Bauer, G.; Redman, N.; Travers, R. Improving the Health of Trans Communities: Findings from the Trans PULSE Project [Conference Plenary]. In Proceedings of the Trans-Health Advocacy Summit, London, ON, Canada, 11 August 2012; Available online: https://transpulseproject.ca/research/improving-the-health-of-trans-communities-findings-from-the-trans-pulse-project/ (accessed on 15 August 2021).
  58. Cuevas, A.; O’Brien, K.; Saha, S. Can Patient-Centered Communication Reduce the Effects of Medical Mistrust on Patients’ Decision Making? Health Psychol. 2019, 38, 325–333. [Google Scholar] [CrossRef] [PubMed]
  59. Jamison, A.; Quinn, S.; Freimuth, V. “You don’t trust a government vaccine”: Narratives of institutional trust and influenza vaccination among African American and white adults. Soc. Sci. Med. 2019, 221, 87–94. [Google Scholar] [CrossRef] [PubMed]
  60. Matijczak, A.; Applebaum, J.W.; Kattari, S.K.; McDonald, S.E. Social Support and Attachment to Pets Moderate the Association between Sexual and Gender Minority Status and the Likelihood of Delaying or Avoiding COVID-19 Testing. Soc. Sci. 2021, 10, 301. [Google Scholar] [CrossRef]
Table 1. Respondent racial/ethnic identity.
Table 1. Respondent racial/ethnic identity.
Race/Ethnicityn%
Alaska Native10.2%
Asian132.9%
Black71.6%
Latine71.6%
MiddleEastern10.2%
NativeAmerican20.4%
PacificIslander10.2%
White33273.9%
NotListed10.2%
Decline30.7%
Bi/Multi6514.5%
Missing163.6%
Total449100.0%
Table 2. QOL descriptive statistics.
Table 2. QOL descriptive statistics.
VariableMean QOLMinMaxRangeSD
Total Sample23.211531162.944
Women22.881730133.275
Men23.461631152.748
Nonbinary23.181529142.948
White23.131630142.861
BIPOC23.501531163.137
Income <25 k22.921530153.097
Income between 25–40 k22.991531163.210
Income between 40–75 k23.721731142.560
Income >75 k23.741831132.727
Disabled22.671531162.983
Table 3. Predicting COVID-19 impact by demographics.
Table 3. Predicting COVID-19 impact by demographics.
PredictorbSE95% CItp
(constant)3.2920.1792.94, 3.6418.405<0.001 ***
Age0.0030.005−0.01, 0.010.5580.577
Income−0.0110.008−0.03, 0.01−1.3330.182
Women0.2720.1370.00, 0.541.9840.047 *
Nonbinary0.1700.090−0.01, 0.351.8860.059
BIPOC−0.1280.089−0.30, 0.05−1.4430.149
Note: Gender was represented as two dummy variables with men serving as the reference group. * significant at the p < 0.05 level. *** significant at the p < 0.001 level.
Table 4. Predicting QOL by demographics.
Table 4. Predicting QOL by demographics.
PredictorbSE95% CItp
(constant)23.5550.68922.2, 24.9134.171<0.001 ***
Age−0.0300.017−0.06, 0−1.7610.078
Income0.0850.0310.03, 0.152.7690.006 **
Women−0.6450.551−1.73, 0.44−1.1700.242
Nonbinary−0.3590.348−1.04, 0.32−1.0330.302
BIPOC0.4140.351−0.28, 1.11.1780.239
Note: Gender was represented as two dummy variables with men serving as the reference group. ** Significant at the p < 0.01 level. *** Significant at the p < 0.001 level.
Table 5. Predicting COVID-19 impact by QOL and biosocial factors.
Table 5. Predicting COVID-19 impact by QOL and biosocial factors.
PredictorbSE95% CItp
(constant)3.8090.3843.05, 4.569.918<0.001 ***
QOL−0.0220.015−0.05, 0.01−1.4660.143
Disabled0.1430.096−0.05, 0.331.4910.137
Fem(me)0.0680.085−0.10, 0.240.8020.423
Degree of being out as trans to others−0.0090.024−0.06, 0.04-0.3900.696
*** Significant at the p < 0.001 level.
Table 6. Correlating gender identity and gender expression.
Table 6. Correlating gender identity and gender expression.
VariableMenMascEnbyAndroWomen
Masc0.385 **
Enby−0.767 **−0.196 **
Andro−0.355 **−0.137 **0.443 **
Women−0.208 **−0.232 **−0.468 **−0.185 **
Fem−0.292 **−0.395 **0.021 **−0.041 **0.371 **
** Correlation is significant at the 0.01 level (2-tailed).
Table 7. Predicting odds ratios for subgroups.
Table 7. Predicting odds ratios for subgroups.
PredictorOR95% CIp
Predicting low income (i.e., <25 k).
fem(me) BIPOC1.92380.482, 3.4050.620
masc(uline) BIPOC0.75490.197, 1.1070.084
masc(uline) white0.80490.548, 1.3530.516
disabled white1.05610.778, 2.1050.331
disabled BIPOC1.40350.806, 5.4530.129
nondisabled BIPOC0.95070.496, 4.1750.504
Predicting feeling “very” or “extremely” safe in daily life.
fem(me) BIPOC0.70460.3410, 2.9760.949
masc(uline) BIPOC1.5611.028, 6.2050.043 *
masc(uline) white1.18640.758, 1.8890.442
disabled white0.55050.233, 0.661<0.001 ***
disabled BIPOC0.72980.109, 0.7280.009 **
nondisabled BIPOC1.57010.196, 1.8230.365
Note: The intersection between gender expression and race [represented by four categories: fem(me)BIPOC, masc(uline)BIPOC, fem(me)BIPOC, masc(uline)white] was analyzed using three dummy variables with fem(me) white respondents serving as the reference group. The intersection between ability and race (categorized into disabledwhite, disabledBIPOC, nondisabledwhite, nondisabledBIPOC) was represented by three dummy variables with nondisabled white respondents serving as the reference group for this analysis. * Significant at the p < 0.05 level. ** Significant at the p < 0.01 level. *** Significant at the p < 0.001 level.
Table 8. Predicting QOL by intersecting identities.
Table 8. Predicting QOL by intersecting identities.
PredictorbSE95% CItp
(constant)23.7760.40022.988, 24.56559.380<0.001 ***
femmeBIPOC−0.0960.700−1.469, 1.277−0.1370.891
mascWHITE0.4280.339−0.237, 1.0941.2620.207
mascBIPOC0.6220.704−0.760, 2.0040.8840.377
disabledBIPOC−1.1490.664−2.452, 0.153−1.7310.084
disabledWHITE−1.3780.370−2.104, −0.653−3.728<0.001 ***
nondisabled BIPOC0.7910.800−0.779, 2.3620.9890.323
Note: The intersection between gender expression and race [represented by four categories: fem(me)BIPOC, masc(uline)BIPOC, fem(me)BIPOC, masc(uline)white] was analyzed using three dummy variables with fem(me) white respondents serving as the reference group. The intersection between ability and race (categorized into disabledwhite, disabledBIPOC, nondisabledwhite, nondisabledBIPOC) was represented by three dummy variables with nondisabled white respondents serving as the reference group for this analysis. *** Significant at the p < 0.001 level.
Table 9. Predicting COVID-19 impact by intersecting identities.
Table 9. Predicting COVID-19 impact by intersecting identities.
PredictorbSE95% CItp
(constant)3.4650.0943.280, 3.65036.798<0.001 ***
femmeBIPOC0.1290.191−0.245, 0.5030.6760.499
mascWHITE−0.2100.094−0.394, −0.026−2.2390.025 *
mascBIPOC−0.1540.168−0.484, 0.175−0.9200.358
disabledBIPOC−0.0110.167−0.338, 0.316−0.0640.949
disabledWHITE0.0930.101−0.104, 0.2910.9280.354
nondisabled BIPOC−0.3990.204−0.799, 0.001−1.9570.051
Note: The intersection between gender expression and race [represented by four categories: fem(me)BIPOC, masc(uline)BIPOC, fem(me)BIPOC, masc(uline)white] was analyzed using three dummy variables with fem(me) white respondents serving as the reference group. The intersection between ability and race (categorized into disabledwhite, disabledBIPOC, nondisabledwhite, nondisabledBIPOC) was represented by three dummy variables with nondisabled white respondents serving as the reference group for this analysis. * Significant at the p < 0.05 level. *** Significant at the p < 0.001 level.
Table 10. Vaccine preferences by demographics.
Table 10. Vaccine preferences by demographics.
VariableASAPMinimum
Side Effects
After More
Vulnerable Groups
Total
n%n%n%n%
Age.
18–242629.21%3337.08%3337.08%8919.82%
25–349340.43%7733.48%7934.35%23051.22%
35–443539.33%2528.09%2629.21%8919.82%
45+1024.39%1536.59%1024.39%419.13%
Gender.
women1835.29%1835.29%1223.53%5111.36%
men4035.09%4337.72%3732.46%11425.39%
nonbinary10637.32%8931.34%9934.86%28463.25%
Race.
White12737.91%11534.33%11935.52%33574.61%
BIPOC3632.43%3430.63%2825.23%11124.72%
Disabled and/or Chronically Ill.
yes11639.19%11237.84%10334.80%29665.92%
no4831.37%3824.84%4529.41%15334.08%
Income.
Under 25 k6632.04%7033.98%7234.95%20645.88%
over 75 k2345.10%1427.45%1325.49%5111.36%
Live in the U.S.
yes14536.16%13734.16%13032.42%40189.31%
no1939.58%1327.08%1837.50%4810.69%
Health conditions.
neither1412.28%97.89%108.77%11425.39%
mental8444.92%7841.71%8545.45%18741.65%
physical327.27%763.64%436.36%112.45%
both6345.99%5640.88%4935.77%13730.51%
Total16436.53%15033.41%14832.96%449100%
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Harner, V.; Munion, A.K.; Shelton, J. Trans Adults Amidst the COVID-19 Pandemic: Quality of Life, Pandemic Impact, and Vaccine Preferences. Int. J. Environ. Res. Public Health 2021, 18, 12536. https://doi.org/10.3390/ijerph182312536

AMA Style

Harner V, Munion AK, Shelton J. Trans Adults Amidst the COVID-19 Pandemic: Quality of Life, Pandemic Impact, and Vaccine Preferences. International Journal of Environmental Research and Public Health. 2021; 18(23):12536. https://doi.org/10.3390/ijerph182312536

Chicago/Turabian Style

Harner, Vern, Ascher K. Munion, and Jama Shelton. 2021. "Trans Adults Amidst the COVID-19 Pandemic: Quality of Life, Pandemic Impact, and Vaccine Preferences" International Journal of Environmental Research and Public Health 18, no. 23: 12536. https://doi.org/10.3390/ijerph182312536

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop